KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to -$202.4 million.

  • Novavax's Income towards Parent Company fell 6684.17% to -$202.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.7 million, marking a year-over-year increase of 21997.03%. This contributed to the annual value of -$187.5 million for FY2024, which is 6560.04% up from last year.
  • Per Novavax's latest filing, its Income towards Parent Company stood at -$202.4 million for Q3 2025, which was down 6684.17% from $106.5 million recorded in Q2 2025.
  • Novavax's 5-year Income towards Parent Company high stood at $518.6 million for Q1 2025, and its period low was -$846.3 million during Q4 2021.
  • In the last 5 years, Novavax's Income towards Parent Company had a median value of -$168.6 million in 2022 and averaged -$142.7 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first plummeted by 191082.7% in 2021, then soared by 45150.53% in 2025.
  • Novavax's Income towards Parent Company (Quarter) stood at -$846.3 million in 2021, then skyrocketed by 78.46% to -$182.2 million in 2022, then increased by 2.12% to -$178.4 million in 2023, then surged by 54.58% to -$81.0 million in 2024, then plummeted by 149.76% to -$202.4 million in 2025.
  • Its last three reported values are -$202.4 million in Q3 2025, $106.5 million for Q2 2025, and $518.6 million during Q1 2025.